top of page
Search


New EU Guidance Clarifies Clinical Evidence Requirements for Orphan IVDs
Regulatory Update | In Vitro Diagnostic Medical Devices | November 2026 On 3 November 2026, the Medical Device Coordination Group (MDCG) published MDCG 2026-6: Clinical Evidence for Orphan In Vitro Diagnostic Medical Devices. The guidance tackles a real challenge under the EU's In Vitro Diagnostic Medical Devices Regulation (IVDR): demonstrating sufficient clinical evidence for tests intended for rare diseases, uncommon conditions, or exceptional clinical circumstances. Belgi

ARQon
4 days ago4 min read


Belgium Strengthens Medical Device Oversight Through National Regulatory Authority
Belgium continues to play an important role in the European regulatory landscape for medical devices, with a strong focus on compliance, safety monitoring, and alignment with European regulatory frameworks. The country’s national regulator, the Federal Agency for Medicines and Health Products (FAMHP), oversees the regulation of medicines and medical devices placed on the Belgian market. As the European Union continues to implement the European Union Medical Device Regulation

ARQon
Mar 232 min read


Belgium: Reminder End of Transition Period & Important Year-End Deadlines for Submitting Dossiers to the FAMHP
End of Transition Period for Clinical Trials FAHMP reminds all stakeholders, that starting from 31 January 2025 , all clinical trials...

ARQon
Nov 6, 20241 min read
bottom of page
.png)